BIOMAT Database Logo BIOMAT Database Logo

T-cell dysfunctions in hu-PBL-SCID mice infected with human immunodeficiency virus (HIV) shortly after reconstitution: in vivo effects of HIV on highly activated human immune cells. 1996

P Rizza, and S M Santini, and M A Logozzi, and C Lapenta, and P Sestili, and G Gherardi, and R Lande, and M Spada, and S Parlato, and F Belardelli, and S Fais
Laboratory of Virology, Istituto Superiore di Sanita, Rome, Italy.

The state of activation of the immune system may be an important factor which renders a host more receptive to human immunodeficiency virus (HIV) and more vulnerable to its effects. To explore this issue with a practical in vivo model, we developed a modified protocol of HIV infection in hu-PBL-SCID mice. First, we assessed the time course of activation of human peripheral blood lymphocytes (hu-PBL) in the peritoneal cavity of SCID mice. At 2 to 24 h after the intraperitoneal injection into SCID mice, there was a clear-cut increase in the percentage of hu-PBL expressing early activation markers (CD69), concomitant with the release of soluble intercellular adhesion molecule-1 (sICAM-1) and the soluble interleukin-2 receptor (sIL-2R) and with the accumulation of mRNAs for a number of human cytokines. At 2 weeks, virtually all of the hu-PBL expressed the memory phenotype (CD45RO) and HLA-DR antigens as well. Cells collected from the SCID mouse peritoneum at 2 and 24 h after transplantation were fully susceptible to in vitro infection with HIV type 1 (HIV-1) in the absence of either IL-2 or mitogens. The injection of HIV into hu-PBL-SCID mice at 2 h after reconstitution resulted in a generalized and productive HIV infection of the xenochimeras. This early HIV-1 infection resulted in a dramatic depletion of human CD4+ cells and in decreased levels of sICAM-1 (in the peritoneal lavage fluid) as well as of sIL-2R and immunoglobulins M and A (in the serum). Enzyme-linked immunosorbent assay and/or reverse transcriptase PCR analysis showed higher levels of IL-4, IL-5, and IL-10 in the HIV-infected animals than in control hu-PBL-SCID mice, while gamma interferon levels in the two groups were comparable. When we compared the current model of HIV-1 infection at 2 weeks after the intraperitoneal injection of the hu-PBL in the SCID mice with the model described here, we found that the majority of immune dysfunctions induced in the 2-h infection of the xenochimeras are not inducible in the 2-week infection. This supports the concept that the state of activation of human cells at the moment of the in vivo infection with HIV-1 is a crucial factor in determining the immune derangement observed in AIDS patients. These results show that some immunological dysfunctions induced by HIV infection in AIDS patients can be mimicked in this xenochimeric model. Thus, the hu-PBL-SCID mouse model may be useful in exploring, in vivo, the relevance of hu-PBL activation and differentiation in HIV-1 infection and for testing therapeutic intervention directed towards either the virus or the immune system.

UI MeSH Term Description Entries
D007963 Leukocytes, Mononuclear Mature LYMPHOCYTES and MONOCYTES transported by the blood to the body's extravascular space. They are morphologically distinguishable from mature granulocytic leukocytes by their large, non-lobed nuclei and lack of coarse, heavily stained cytoplasmic granules. Mononuclear Leukocyte,Mononuclear Leukocytes,PBMC Peripheral Blood Mononuclear Cells,Peripheral Blood Human Mononuclear Cells,Peripheral Blood Mononuclear Cell,Peripheral Blood Mononuclear Cells,Leukocyte, Mononuclear
D010641 Phenotype The outward appearance of the individual. It is the product of interactions between genes, and between the GENOTYPE and the environment. Phenotypes
D002478 Cells, Cultured Cells propagated in vitro in special media conducive to their growth. Cultured cells are used to study developmental, morphologic, metabolic, physiologic, and genetic processes, among others. Cultured Cells,Cell, Cultured,Cultured Cell
D004195 Disease Models, Animal Naturally-occurring or experimentally-induced animal diseases with pathological processes analogous to human diseases. Animal Disease Model,Animal Disease Models,Disease Model, Animal
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D013601 T-Lymphocytes Lymphocytes responsible for cell-mediated immunity. Two types have been identified - cytotoxic (T-LYMPHOCYTES, CYTOTOXIC) and helper T-lymphocytes (T-LYMPHOCYTES, HELPER-INDUCER). They are formed when lymphocytes circulate through the THYMUS GLAND and differentiate to thymocytes. When exposed to an antigen, they divide rapidly and produce large numbers of new T cells sensitized to that antigen. T Cell,T Lymphocyte,T-Cells,Thymus-Dependent Lymphocytes,Cell, T,Cells, T,Lymphocyte, T,Lymphocyte, Thymus-Dependent,Lymphocytes, T,Lymphocytes, Thymus-Dependent,T Cells,T Lymphocytes,T-Cell,T-Lymphocyte,Thymus Dependent Lymphocytes,Thymus-Dependent Lymphocyte
D013997 Time Factors Elements of limited time intervals, contributing to particular results or situations. Time Series,Factor, Time,Time Factor
D014181 Transplantation Immunology A general term for the complex phenomena involved in allo- and xenograft rejection by a host and graft vs host reaction. Although the reactions involved in transplantation immunology are primarily thymus-dependent phenomena of cellular immunity, humoral factors also play a part in late rejection. Immunology, Transplantation

Related Publications

P Rizza, and S M Santini, and M A Logozzi, and C Lapenta, and P Sestili, and G Gherardi, and R Lande, and M Spada, and S Parlato, and F Belardelli, and S Fais
Distinct rate and patterns of human CD4+ T-cell depletion in hu-PBL-SCID mice infected with different isolates of the human immunodeficiency virus.
November 1995, Journal of clinical immunology,
P Rizza, and S M Santini, and M A Logozzi, and C Lapenta, and P Sestili, and G Gherardi, and R Lande, and M Spada, and S Parlato, and F Belardelli, and S Fais
The human immune system in hu-PBL-SCID mice.
November 1995, Immunology today,
P Rizza, and S M Santini, and M A Logozzi, and C Lapenta, and P Sestili, and G Gherardi, and R Lande, and M Spada, and S Parlato, and F Belardelli, and S Fais
Quantitative assessment of human immunodeficiency virus type 1 replication in human xenografts of acutely infected Hu-PBL-SCID mice.
March 1994, AIDS research and human retroviruses,
P Rizza, and S M Santini, and M A Logozzi, and C Lapenta, and P Sestili, and G Gherardi, and R Lande, and M Spada, and S Parlato, and F Belardelli, and S Fais
Transfer of human CD4(+) T lymphocytes producing beta interferon in Hu-PBL-SCID mice controls human immunodeficiency virus infection.
December 1999, Journal of virology,
P Rizza, and S M Santini, and M A Logozzi, and C Lapenta, and P Sestili, and G Gherardi, and R Lande, and M Spada, and S Parlato, and F Belardelli, and S Fais
Human immunodeficiency virus infection of human-PBL-SCID mice.
February 1991, Science (New York, N.Y.),
P Rizza, and S M Santini, and M A Logozzi, and C Lapenta, and P Sestili, and G Gherardi, and R Lande, and M Spada, and S Parlato, and F Belardelli, and S Fais
EBV-induced human B cell lymphomas in hu-PBL-SCID mice.
May 1992, AIDS research and human retroviruses,
P Rizza, and S M Santini, and M A Logozzi, and C Lapenta, and P Sestili, and G Gherardi, and R Lande, and M Spada, and S Parlato, and F Belardelli, and S Fais
Disseminated human immunodeficiency virus 1 (HIV-1) infection in SCID-hu mice after peripheral inoculation with HIV-1.
February 1994, The Journal of experimental medicine,
P Rizza, and S M Santini, and M A Logozzi, and C Lapenta, and P Sestili, and G Gherardi, and R Lande, and M Spada, and S Parlato, and F Belardelli, and S Fais
Regulation of human IgE response in hu-PBL-SCID mice.
October 1993, Cellular immunology,
P Rizza, and S M Santini, and M A Logozzi, and C Lapenta, and P Sestili, and G Gherardi, and R Lande, and M Spada, and S Parlato, and F Belardelli, and S Fais
hu-PBL-SCID mice: a model for human immune function, AIDS, and lymphomagenesis.
December 1991, Immunological reviews,
P Rizza, and S M Santini, and M A Logozzi, and C Lapenta, and P Sestili, and G Gherardi, and R Lande, and M Spada, and S Parlato, and F Belardelli, and S Fais
Induction of protective immune responses against R5 human immunodeficiency virus type 1 (HIV-1) infection in hu-PBL-SCID mice by intrasplenic immunization with HIV-1-pulsed dendritic cells: possible involvement of a novel factor of human CD4(+) T-cell origin.
August 2003, Journal of virology,
Copied contents to your clipboard!